F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom
The committee endorsed broader use of the peptides in lightly [...]
Targeting Hims & Hers, F.D.A. Takes on a New Type of Drug Advertiser
Regulators sent about 100 warning letters this week to drug [...]
Trump Moves to Crack Down on Drug Advertising
The administration is proposing a return to a 1990s-era policy [...]
Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats
U.S. regulators are trying to shut down the industry for [...]